Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Acro Biomedical (ACBM) Total Liabilities (2016 - 2025)

Acro Biomedical (ACBM) has 10 years of Total Liabilities data on record, last reported at $401062.0 in Q4 2025.

  • For Q4 2025, Total Liabilities rose 22.67% year-over-year to $401062.0; the TTM value through Dec 2025 reached $401062.0, up 22.67%, while the annual FY2025 figure was $401062.0, 22.67% up from the prior year.
  • Total Liabilities reached $401062.0 in Q4 2025 per ACBM's latest filing, down from $436942.0 in the prior quarter.
  • Across five years, Total Liabilities topped out at $436942.0 in Q3 2025 and bottomed at $60158.0 in Q2 2021.
  • Average Total Liabilities over 5 years is $246499.2, with a median of $284318.5 recorded in 2021.
  • Peak YoY movement for Total Liabilities: crashed 74.71% in 2021, then surged 188.18% in 2023.
  • A 5-year view of Total Liabilities shows it stood at $117370.0 in 2021, then skyrocketed by 71.35% to $201116.0 in 2022, then soared by 56.86% to $315473.0 in 2023, then increased by 3.64% to $326946.0 in 2024, then rose by 22.67% to $401062.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $401062.0 in Q4 2025, $436942.0 in Q3 2025, and $370797.0 in Q2 2025.